The herpes simplex virus (HSV) treatment market represents a significant segment within the global infectious disease therapeutics landscape. Herpes simplex virus infections, primarily classified as HSV-1 (oral herpes) and HSV-2 (genital herpes), affect millions of people worldwide. With no definitive cure currently available, the demand for effective antiviral therapies, symptom...